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Abstract
Background: ChIP-Seq and ChIP-PET can potentially be used with any genome for genome wide
profiling of protein-DNA interactio n  s i t e s .  U n f o r t u n a t e l y ,  i t  i s  p r o b a b l e  t h a t  m o s t  g e n o m e
assemblies will never reach the quality of the human genome assembly. Therefore, it remains to be
determined whether ChIP-Seq and ChIP-PET are practicable with genome sequences other than a
few (e.g. human and mouse).
Findings: Here, we used in silico simulations to assess the impact of completeness or fragmentation
of genome assemblies on ChIP-Seq and ChIP-PET data mapping.
Conclusions: Most currently published genome assemblies are suitable for mapping the short
sequence tags produced by ChIP-Seq or ChIP-PET.
Background
In the past few years, next-generation sequencing technol-
ogies have fuelled a plethora of studies providing genome
wide profiling of transcription factor DNA binding sites
(TFBS) [1,2] and histone modifications [3-6]. These data
are of highly fundamental and applied relevance, as exem-
plified by the recent ChIP-Seq based profiling of 15 key
stem cell-specific transcription factors binding sites, in
mouse [2]. These technologies, which combine reduced
cost, speed and effectiveness, have been primarily devel-
oped to be used together with high quality genome assem-
blies (although not necessarily complete), such as those of
human [1], mouse [2], drosophila [7], yeast [8] and arabi-
dopsis [9].
ChIP-Seq is a new application of chromatin immuno-pre-
cipitation technologies and is particularly adapted to map
protein-DNA contacts across the genome. To this end,
chromatin is fragmented and immuno-precipitated with
an antibody raised against a DNA binding protein and
one end of each purified DNA fragment is sequenced with
an ultra-high throughput sequencer. ChIP-PET [10,11] is
similar to ChIP-Seq except that the two ends are
sequenced, thus providing greater specificity in mapping
the reads to the genome.
The number of sequence tags at any genomic location is a
quantitative value, which reflects the local enrichment of
the DNA-bound protein, and clusters of tags (peaks) are
used to define TFBS.
Sequence tags mapping, by which the short sequence
reads (tags) produced by ultra-high throughput sequenc-
ing are mapped onto a reference genome sequence, is a
critical step since it will dictate the outcome of down-
stream analyses. Thus, the bioinformatic analysis of ChIP-
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Seq and ChIP-PET data implicitly relies on the quality of
the reference genome assembly both for sequence tags
mapping and for mining the relative position of DNA
binding sites with other functional and structural compo-
nents of the genome [1,5]. Unfortunately, most genome
assemblies correspond to draft genome sequences com-
posed of many scaffolds and containing numerous assem-
bly gaps (unsequenced regions), which can potentially
impair sequence tags mapping. In this paper, we model
ChIP-Seq and ChIP-PET data sequence tags mapping on
draft or incomplete genome sequences. Beyond the obvi-
ous fact that if the binding sites occur in the known parts
of the genome they will be detected, our data suggest that
the state of a genome assembly has a limited impact on
sequences tags mapping and that most genome assem-
blies are readily usable for ChIP-Seq and ChIP-PET analy-
sis.
Findings
1. State of assembly
Most genome assemblies released to date have not bene-
fited from extensive curation efforts and do not reach the
high quality standard of a few model organisms, for
which the genome sequences are almost complete and the
sequence of individual chromosomes has been recon-
structed. Indeed, the human and mouse genome assem-
blies are respectively composed of 24 chromosomes and
22 chromosomes together with a few unmapped scaf-
folds. In other cases, it is instead a draft sequence, almost
always fragmented into many scaffolds (see Additional
file 1: Figure S1, and Additional file 2: Table S1). For
example, although the platypus genome assembly is
about the same size as the mouse genome assembly, it is
composed of ~291,000 scaffolds with an average size of
6.8 kb compared to 22 chromosome of ~60 to 200 Mb.
Surprisingly, a few unpublished genome assemblies are
less fragmented than published ones. This is the case, for
example, of the xenopus genome assembly, which is inter-
mediate between mouse's and platypus', with a total of
~20,000 scaffolds and an average scaffold size of 77 kb.
Importantly, a limited subset of 1,440 scaffolds represents
~90% of the assembly, which further shows the relatively
low level of fragmentation of this assembly. This contrasts
sharply with platypus where ~90% of the assembly is rep-
resented by 35,779 scaffolds (genome assemblies availa-
ble at ENSEMBL web site [12]).
2. Completeness of assemblies
The sequenced fraction of published assemblies is also
quite variable and ranks from ~70% to ~100% (for Ciona
intestinalis and Cenorhabditis elegans, respectively). Impor-
tantly, almost all (98.5%) Ns found in genome assemblies
released to date are part of stretches of at least five consec-
utive Ns. This means that virtually all Ns actually corre-
spond to assembly gaps (unsequenced regions) rather
than isolated sequencing ambiguities. In published draft
sequences, unsequenced gaps represent 2.94% to 28.3%
of the assembly (for Monodelphis domestica and Takifugu
rubripes, respectively). Thus, they are a potential pitfall for
ChIP-Seq and ChIP-PET sequence reads mapping as many
DNA binding sites may be missed. Therefore, these data
suggest that although ChIP-Seq and ChIP-PET proved to
have a remarkable resolution in mouse and human, their
application to other sequenced genomes remains an open
question. A key point is that currently available (as well as
future) assemblies will certainly not benefit from curation
efforts similar to those of a few model organism and are
unlikely to reach their quality standard. This is a severe
limitation to the application of ChIP-Seq and ChIP-PET to
other genomes. It is therefore critical to assess whether
one can make use of ChIP-Seq technologies with the exist-
ing genome assemblies. We addressed this issue by mod-
elling ChIP-Seq and ChIP-PET data mapping in silico.
3. Mapping simulations
3.1 Rationale
In silico simulation of ChIP-Seq data mapping assumes to
model the distribution of sequence reads frequency and
depth. These models can be complex to build in part
because the DNA-binding domain of a transcription fac-
tor is susceptible to bind to different sequence. Further-
more, the distribution of assembly gaps may be specific to
each assembly since it depends on the software algorithm,
sequencing libraries used to build it and the underlying
structure of the genome. Therefore, in order to rule out
inaccurate models, we undertook a brute force approach
and turned top quality genome assemblies into ones that
reflect those at different levels of assembly ('xenopiza-
tion', 'batization', 'bovization'...), by fragmenting and
introducing assembly gaps taken from a query assembly
into the human or mouse genome assemblies (see
below). Thus, xenopization fragments human/mouse
genome assembly in a manner similar to that of Xenopus
tropicalis, bovization to that of Bos taurus and so on (Figure
1). We then scored the mapping efficiency of the mouse
ChIP-Seq and human ChIP-PET data with the modified
assemblies (see Methods). One can then assess the poten-
tial impact of the completeness of genome assembly onto
human and mouse ChIP-Seq and ChIP-PET data map-
ping. Simply put, the question being asked is what would
be the ChIP-Seq and ChIP-PET mapping outcome if the
reference sequences (from human or mouse assembly)
were similar to those of bat or xenopus? By extension, this
can be used to estimate the probable success of ChIP-Seq
and ChIP-PET mapping with the corresponding genome
assembly.
3.2. Mapping of ChIP-Seq data
To this end, we first used the ChIP-Seq datasets obtained
for 15 mouse embryonic stem cell specific transcriptionBMC Research Notes 2009, 2:257 http://www.biomedcentral.com/1756-0500/2/257
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Principle of in silico simulations of ChIP-Seq tags mapping with gapped genome assemblies Figure 1
Principle of in silico simulations of ChIP-Seq tags mapping with gapped genome assemblies. In this example, the 
Xenopus scaffolds and the mouse chromosomes were concatenated in a random order and placed along each other. Each Xeno-
pus assembly gap was then transposed onto the mouse genome, which was further sliced in order to reflect the fragmented 
nature of the Xenopus genome assembly. ChIP-Seq sequence reads were mapped with bowtie on the 'xenopized' mouse 
genome. Sequence reads mapping at multiple locations were discarded and peak calling was carried out with sissrs. The proc-
ess is reiterated 20 times for statistical robustness. With ChIP-PET, the process is similar except that the two ends of each 
sequence read are mapped.
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factors (plus an additional GFP control, [2]). Using the
mapping simulation pipeline (see Methods), we surveyed
the genome assemblies available at the ENSEMBL website
(statistics available in Additional file 2: Table S1) and
measured the ChIP-Seq data mapping success of all 15
transcription factors datasets (Additional file 3: Table S2).
The rate of successful mapping of ChIP-Seq tags ranks
from 100% for Arabidposis thaliana, which has almost no
assembly gaps, to 46.82% for Felis catus, the genome of
which is currently partially sequenced (Additional file 3:
Table S2). Not surprisingly, DNA binding sites are missed
less often (by 3% to 5%) than isolated tags. Among pub-
lished genome sequences, the mapping success observed
with  Tetraodon nigroviridis assembly parameters proved
surprisingly low with ~25% missed tags. This probably
reflects the fact that this assembly is composed of ~30%
assembly gaps. Overall, the unsequenced fraction of an
assembly (i.e. the cumulated gap size) is a good estimator
of the ChIP-Seq data mapping outcome, although it tends
to overestimates it by ~5-10%. We also note that the rate
of successful mapping is very similar between the 15 tran-
scription factors tested, which have clear distinct DNA
binding properties (number of sites across the genome,
tag density per DNA binding site, [2]).
3.3. Mapping of ChIP-PET data
We next assessed mapping success with the ChIP-PET data
sets obtained with human p53 and STAT1 transcription
factors [10]. The difference between this dataset and the
ChIP-Seq datasets is two fold: 1) the ChIP-PET sequencing
depth is somewhat lower and 2) the two ends of each
chromatin fragment are being sequenced (di-tags). To this
end, we adapted to procedure detailed above to the ChIP-
PET data. Results were virtually identical to those
obtained with ChIP-Seq (Additional file 4: Table S3). The
successful mapping of the two ends ranks from 99.5% for
Arabidposis thaliana to 42.06% for Felis catus. Failure to
map the two ends follows an opposite trend, from 0 for
Danio rerio to 48.77% for Dasypus novemcinctus. Single end
mapping ranks from 0.02% to 12.5%. The fragmentation
of a genome assembly has a limited impact on ChIP-PET
data mapping efficiency. For example, the genome assem-
bly of Takifugu rubripes is composed of ~7,000 scaffolds
and that of Xenopus tropicalis of ~20,000 scaffolds, but they
display similar one and two ends mapping success (Addi-
tional file 4: Table S3).
Conclusions
Collectively, these results show that assembly gaps and
fragmentation of the mouse and human genome
sequence do not prevent mapping of ChIP-Seq and PET-
ChIP data. By extension, one can infer that most genome
assemblies are suitable for ChIP-Seq and ChIP-PET analy-
sis. Also, the fact that a draft genome sequence is pub-
lished does not guarantee a high mapping efficiency, as
exemplified by Tetraodon nigroviridis, for which mapping
efficiency was found surprisingly low.
Our conclusions can be extended to research areas based
on high throughput sequencing other than mapping of
protein-DNA interaction sites, such as genome resequenc-
ing, SNP detection and other di-tag sequencing technolo-
gies.
Methods
Statistics of genome assemblies
Statistics of genome assemblies were computed with a
simple python script.
Mapping assessment pipeline
For a given ChIP-Seq dataset, the mapping simulation
pipeline described below was run for the genome assem-
blies available at ENSEMBL website.
Mouse chromosomes were randomly joined together in
order to form an artificially long chromosome (ALC).
Each scaffold of the test assembly was then randomly
selected and its gap content transposed into the left end of
the ALC, which was further truncated in a fragment of the
scaffold' size (Figure 1). This process was iterated over all
the scaffolds of the test assembly. The resulting assembly
(e.g. xenopized assembly, if the test assembly is that of
Xenopus tropicalis) was used as a reference to map ChIP-
Seq datasets [2] (GEO accession number GSE11431, 26
bp sequence reads) with bowtie [13] (version 0.10.0),
using stringent parameters (-q -l24 -m 3, i.e. up to two
mismatches; quality values are ignored). Sequence reads
mapping at multiple genomic locations were discarded.
Transcription factor binding sites were detected ("Peak
calling", Figure 1) with sissrs [14], run with a false discov-
ery rate of 1‰. The whole process was reiterated 20 times
for statistical robustness. This dataset correspond to 15
transcription factors (plus one control) which have differ-
ent DNA binding properties and number of binding sites,
and thus represent an ideal benchmark tool. All the data-
sets were initially mapped on the mouse genome in order
to benchmark the mapping and peak calling parameters.
We found a similar number of TFBS to those reported by
[2]. For mapping assessment of ChIP-PET data (from
[10]), the process is essentially the same, except that the
two ends of each PET are mapped and that assembly gaps
are introduced in the human genome.
Of notes, this procedure does not ask directly whether the
query assembly is suitable for ChIP-Seq mapping, rather it
scores the mapping efficiency of the ChIP-Seq data if they
had been carried out on the subject assembly fragmented
and containing as many assembly gaps as in the query.
The procedure was encapsulated in a python script, usingPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Research Notes 2009, 2:257 http://www.biomedcentral.com/1756-0500/2/257
Page 5 of 5
(page number not for citation purposes)
the "random" built-in module. Crucially, this module
uses Mersenne Twister as the core generator, which is
probably the most extensively tested and reliable random
number generator.
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Additional file 1
Figure S1. Genome sequences are often fragmented in many scaffolds 
containing unsequenced gaps. For each genome assembly available at 
ENSEMBL, the size and the unsequenced percent of each scaffold has 
been plotted.
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Additional file 2
Table S1. Statistics of genome assemblies. For a few species (grayed 
name), the estimated ChIP-Seq and ChIP-PET mapping efficiency is par-
ticularly low.
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Table S2. Outcome of simulated ChIP-Seq mapping.
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Table S3. Outcome of simulated ChIP-PET mapping.
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